↓ Skip to main content

MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy

Overview of attention for article published in Journal of Translational Medicine, December 2012
Altmetric Badge

Citations

dimensions_citation
73 Dimensions

Readers on

mendeley
79 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy
Published in
Journal of Translational Medicine, December 2012
DOI 10.1186/1479-5876-10-250
Pubmed ID
Authors

Consolación Melguizo, Jose Prados, Beatriz González, Raul Ortiz, Angel Concha, Pablo Juan Alvarez, Roberto Madeddu, Gloria Perazzoli, Jaime Antonio Oliver, Rodrigo López, Fernando Rodríguez-Serrano, Antonia Aránega

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 79 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 1 1%
Brazil 1 1%
India 1 1%
Nigeria 1 1%
United States 1 1%
Unknown 74 94%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 16 20%
Student > Master 11 14%
Student > Bachelor 8 10%
Researcher 7 9%
Student > Doctoral Student 6 8%
Other 17 22%
Unknown 14 18%
Readers by discipline Count As %
Medicine and Dentistry 28 35%
Biochemistry, Genetics and Molecular Biology 12 15%
Agricultural and Biological Sciences 9 11%
Neuroscience 7 9%
Linguistics 1 1%
Other 4 5%
Unknown 18 23%